Sublingual nitrate plus 99tcm-tetrofosmin infusion in the detection of severely ischaemic but viable myocardium a comparative study with stress, redistribution, reinjection and late redistribution 201T1 imaging

Nuclear Medicine Communications

Volumn 17, Issue 10, 1996, Pages 864-871

  Derebek, E ^a   Durak, H ^a   Ozbilek, E ^a   Capa, G ^a   Yurekli, Y ^a   Degirmenci, B ^a   Dogan, S ^a   Kozan, O ^a   Ergene, O ^a   Belgi, A ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE DINITRATE; TETROFOSMIN TC 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXERCISE; FEMALE; HEART FUNCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBLINGUAL DRUG ADMINISTRATION;

EID: 10544239532     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199610000-00007     Document Type: Article

References (42)

1. Kiat H, Berman DS, Maddahi J. Comparison of planar and tomographic exercise thallium-201 imaging methods for the evaluation of coronary artery disease. J Am Coll Cardiol 1989; 13: 613-616.
2. Maddahi J, Kiat H, Van Train KF et al. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease. Am J Cardiol 1990; 66: 55E-62E.
3. Tamaki N, Takashi N, Kawamoto M et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994; 35: 594-600.
4. Dilsizian V, Rocca TP, Freedman NMT et al. Enhanced detection of ischemic but viable myocardium by reinjection of thallium-201 after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146.
5. Cuocolo A, Pace L, Ricciardelli B et al. Identification of viable myocardium in patients with chronic coronary artery disease: Comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isoni-trile. J Nucl Med 1992; 33: 505-511.
6. Matsunary I, Susuumu F, Taki J et al. Myocardial viability assessment with technetium-99m tetrofosmin and thallium-201 re-injection in coronary artery disease. J Nucl Med 1995; 36: 1961-1967.
7. Bonow RO, Dilsizian V, Cuacolo A, Bacharach SL. Identification of viable myocardium in patients with chronic artery disease and left ventricular dysfunction: Comparison of thallium scintigraphy with reinjection and PET imaging with F-18 Fluorodeoxyglucose. Circulation 1991; 83: 26-37.
8. Tamaki N, Ohtani H, Yamashita K et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: Comparison with positron emission tomography using fluorine-18 deoxyglucose. J Nucl Med 1991; 83: 1247-1255.
9. Ragosta M, Beller GA, Watson DD et al. Quantitative planar rest-redistribution 201 Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87: 1630-1641.
10. Dilsizian V, Perrone-Filardi P, Arrighi JA et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Circulation 1993; 88: 941-952.
11. Roco TP, Dilsizian V, Strauss HW, Boucher CA. Techne-tium-99m isonitrile myocardial uptake at rest: II. Relation to clinical markers of potential viability. J Am Coll Cardiol 1989; 14: 1678-1684.
12. Coleman PS, Metherall JHA, Pandian NG et al. Predicting enhanced regional ventricular function post-revascularization: Comparison of thallium-201 and sestamibi in patients with left ventricular dysfunction (abstract). Circulation 1992; 86 (suppl.): 1-108.
13. Arrighi JA, Diodati JG, Bacharach SL et al. The detection of viable myocardium by Tc-99m sestamibi is enhanced when the severity of irreversible defect is assessed (abstract). Circulation 1992; 86: 1-108.
14. Dilsizian V, Freedman NMT, Bacharach SL et al. Regional thallium uptake in irreversible defects: Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Circulation 1992; 85: 627-634.
15. Ohtani H, Tamaki N, Yonekura Y et al. Value of thallium-201 reinjection after delayed SPECT imaging for prediction of reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990; 66: 394-399.
16. Bartenstein P, Hasfeld M, Schober O et al. Tl-201 reinjection and improvement of left ventricular function following revascularization (abstract). J Nucl Med 1993; 34: 45 P.
17. Perrone-Filardi P, Bacharach SL, Dilsizian V et al. Regional left ventricular wall thickening: Relation to uptake of 18-fluorodeoxyglucose and thallium-201 in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1992; 86: 1125-1137.
18. Kiat H, Berman DS, Maddahi J et al. Late reversibility of tomographic myocardial thallium-201 defect: An accurate marker of myocardial viability. J Am Coll Cardiol 1983; 1: 804-815.
19. van Eck-Smit BLF, van der Wall EE, Zwinderman AH, Pauwels EKJ. Clinical value of immediate thallium-201 reinjection imaging for the detection of ischemic heart disease. Eur Heart J 1995; 16: 410-420.
20. Burns RJ, Galligan L, Wright LM. Thallium infusion scintigraphy improves detection of viable myocardium (abstract). Circulation 1990; 82: 544.
21. Iskandrian AS, Heo J, Kong B et al. Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging. Am J Cardiol 1989; 64: 270-295.
22. Zaret BL, Rigo P, Wackers FJT et al. Myocardial perfusion imaging with Tc-99m tetrofosmin: Comparison to Tl-201 imaging and coronary angiography in a phase III multicenter trial. Circulation 1991; 2: 313-319.
23. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992; 33: 1925-1930.
24. Udelson JE, Coleman PS, Matheral JA et al. Predicting recovery of severe regional ventricular dysfunction: Comparison of resting scintigraphy with thallium-201 and tech-netium-99m sestamibi. Circulation 1994; 89: 2552-2561.
25. Dilsizian V, Arrighi JA, Diodati JG et al. Myocardial viability in patients with chronic ischemic left ventricular dysfunction: Comparison of Tc-99m sestamibi, thallium-201 and F-18 fluorodeoxyglucose. Circulation 1994; 89: 578-587.
26. Hendel RC, Parker MA, Wackers FJT et al. Reduced variability of interpretation and improved image quality with technetium-99m myocardial perfusion agent: Comparison of thallium 201 and technetium 99m-labeled tetrofosmin. J Nucl Cardiol 1994; 1: 509-514.
27. Rigo P, Leclerq B, Itti R et al. Technetium-99m-tetrofosmin myocardial imaging: A comparison with thallium-201 and angiography. J Nucl Med 1994; 35: 587-593.
28. Heo J, Cave V, Wasserleben V, Iskandrian AS. Planar and tomographic imaging with technetium-99m labeled tetrofosmin: Correlation with thallium-201 and coronary angiography. J Nucl Med 1994; 4: 317-324.
29. Platts EA, Powell SL, Gallichan KJ et al. The subcellular localization of Tc-99m in rat myocardium after administration of technetium-99m-tetrofosmin (abstract). First International Congress of Cardiology, 1993, Cannes, France, p. 2214.
30. Sinusas AJ, Shi Q, Saltzberg MT et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: Experimental validation in an intact canine model of ischemia. J Nucl Med 1994; 35: 664-671.
31. Jain D, Wackers FJT, Mattera J et al. Biokinetics of technetium-99m-tetrofosmin imaging agent: Implication for a one-day imaging protocol. J Nucl Med 1993; 34: 1254-1259.
32. Medrano R, Mahmarian JJ, Ashmore RF et al. The enhanced detection of myocardial viability with thallium-201 reinjection after nitroglycerine: A randomized, double blind, parallel, placebo controlled trial using quantitative tomography (abstract). Circulation 1992; 86 (suppl. 1): I-109.
33. Galli M, Marcassa C, Silva P et al. Improvement of resting Tc-99m sestamibi myocardial uptake by acute nitro-glycerine administration (abstract). J Am Coll Cardiol 1993; 21 (suppl. A): 221 A.
34. Scopinaro F, Banci M, Pagan M. Imaging of viable myocardium with Tc-99m sestamibi injected during nitrate infusion (abstract). Eur J Nucl Med 1993; 868: 199.
35. Bisi G, Sciagra R, Santoro GM et al. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility. J Nucl Med 1995; 35: 1274-1278.
36. Cohn JN. Pharmacologic mechanisms of nitrates in myocardial ischemia. Am J Cardiol 1992; 70: 38G-42G.
37. Worsley DF, Fung AY, Jue J, Burns RJ. Identification of viable myocardium with technetium-99m-MIBI infusion. J Nucl Med 1995; 36: 1037-1039. 42.
38. Burns RJ, Wright LM, Lumsden CH et al. Hibernating myocardium: Detection by rest thallium-201 infusion (abstract). Circulation 1993; 88: 534.
39. Miron SD, Finkelhor R, Bahler R et al. Use of Tc-99m sestamibi infusion for detection of hibernating myocardium: A preliminary report. Clin Nucl Med 1995; 20: 440-445.
40. Tartagni F, Fallani F, Corbelli C et al. Detecting hibernating myocardium with SPECT thallium-glucose-insulin infusion. J Nucl Med 1995; 36: 1377-1383.
41. Sinusas AJ, Watson DD, Cannon JM, Beller GA. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labelled methoxyisobutyl isoni-trile and thallium-201. J Am Coll Cardiol 1989; 14: 1785-1793.
42. Songadele JA, Younes A, Maublant Y et al. Uptake of tech-netium-99m-tetrofosmin in isolated mitochondria: Evidence for an active mechanism (abstract). J Nucl Med 1994; 35: 46 P.